Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Of mice and men: the iron age
Sophie Vaulont, … , Lydie Viatte, Axel Kahn
Sophie Vaulont, … , Lydie Viatte, Axel Kahn
Published August 1, 2005
Citation Information: J Clin Invest. 2005;115(8):2079-2082. https://doi.org/10.1172/JCI25642.
View: Text | PDF
Commentary

Of mice and men: the iron age

  • Text
  • PDF
Abstract

Recently, mutations causing juvenile hemochromatosis have been identified in a novel gene, hemojuvelin (HJV), located on chromosome 1. Mouse models of this disease have now been developed by 2 groups, Huang et al. and Niederkofler et al., through targeted disruption of the Hjv gene (see the related articles beginning on pages 2180 and 2187). These mutant mice will allow further investigation into the role of HJV in the regulation of iron homeostasis, a role that to date remains elusive.

Authors

Sophie Vaulont, Dan-Qing Lou, Lydie Viatte, Axel Kahn

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Regulation of systemic iron homeostasis. Increased diferric transferrin,...
Regulation of systemic iron homeostasis. Increased diferric transferrin, Fe2-Tf, is detected by the liver via an as-yet unknown complex regulatory pathway involving HFE, TFR2, and HJV. Hepatocytes respond to this signal by inducing HAMP expression and hepcidin secretion. Circulating hepcidin acts in turn to diminish dietary iron absorption by the enterocytes and iron recycling by the macrophages through the internalization of ferroportin, which blocks iron export. As a consequence, serum iron decreases. As a feedback response, hepcidin synthesis is downregulated, which allows ferroportin molecules to be displayed on the surface of the target cells. In classical and juvenile hemochromatosis the mutations in HFE, TFR2, and HJV lead to abnormal hepcidin regulation, hypohepcidinemia, and ferroportin hyperactivity. The latter results in increased iron absorption and uncontrolled iron release from macrophages, 2 defects characteristic of hereditary hemochromatosis. DMT1, divalent metal transporter 1.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts